4668711000001104: Kaletra capsules (Abbott Laboratories Ltd) (product)

• SNOMED CT Concept\Pharmaceutical / biologic product\...
• \UK product\Actual medicinal product\Kaletra capsules (Abbott Laboratories Ltd)
• \UK product\Virtual medicinal product\Product containing precisely lopinavir 133.3 milligram and ritonavir 33.3 milligram/1 each conventional release oral capsule\Kaletra capsules (Abbott Laboratories Ltd)
• \UK product\Virtual therapeutic moiety\Lopinavir + Ritonavir\Product containing only lopinavir and ritonavir in oral dose form (medicinal product form)\Product containing precisely lopinavir 133.3 milligram and ritonavir 33.3 milligram/1 each conventional release oral capsule\Kaletra capsules (Abbott Laboratories Ltd)
• \UK product\Virtual therapeutic moiety\Lopinavir + Ritonavir\Product containing precisely lopinavir 133.3 milligram and ritonavir 33.3 milligram/1 each conventional release oral capsule\Kaletra capsules (Abbott Laboratories Ltd)
• \UK product\Trade family\Kaletra\Kaletra capsules (Abbott Laboratories Ltd)
• \Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing protease inhibitor\Product containing lopinavir\Product containing lopinavir in oral dose form (medicinal product form)\Product containing lopinavir and ritonavir in oral dose form (medicinal product form)\Product containing only lopinavir and ritonavir in oral dose form (medicinal product form)\Product containing precisely lopinavir 133.3 milligram and ritonavir 33.3 milligram/1 each conventional release oral capsule\Kaletra capsules (Abbott Laboratories Ltd)
• \Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing protease inhibitor\Product containing lopinavir\Product containing lopinavir and ritonavir\Lopinavir + Ritonavir\Product containing only lopinavir and ritonavir in oral dose form (medicinal product form)\Product containing precisely lopinavir 133.3 milligram and ritonavir 33.3 milligram/1 each conventional release oral capsule\Kaletra capsules (Abbott Laboratories Ltd)
• \Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing protease inhibitor\Product containing lopinavir\Product containing lopinavir and ritonavir\Lopinavir + Ritonavir\Product containing precisely lopinavir 133.3 milligram and ritonavir 33.3 milligram/1 each conventional release oral capsule\Kaletra capsules (Abbott Laboratories Ltd)
• \Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing protease inhibitor\Product containing lopinavir\Product containing lopinavir and ritonavir\Product containing lopinavir and ritonavir in oral dose form (medicinal product form)\Product containing only lopinavir and ritonavir in oral dose form (medicinal product form)\Product containing precisely lopinavir 133.3 milligram and ritonavir 33.3 milligram/1 each conventional release oral capsule\Kaletra capsules (Abbott Laboratories Ltd)
• \Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing protease inhibitor\Product containing ritonavir\Product containing ritonavir in oral dose form (medicinal product form)\Product containing lopinavir and ritonavir in oral dose form (medicinal product form)\Product containing only lopinavir and ritonavir in oral dose form (medicinal product form)\Product containing precisely lopinavir 133.3 milligram and ritonavir 33.3 milligram/1 each conventional release oral capsule\Kaletra capsules (Abbott Laboratories Ltd)
• \Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing protease inhibitor\Product containing ritonavir\Product containing lopinavir and ritonavir\Lopinavir + Ritonavir\Product containing only lopinavir and ritonavir in oral dose form (medicinal product form)\Product containing precisely lopinavir 133.3 milligram and ritonavir 33.3 milligram/1 each conventional release oral capsule\Kaletra capsules (Abbott Laboratories Ltd)
• \Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing protease inhibitor\Product containing ritonavir\Product containing lopinavir and ritonavir\Lopinavir + Ritonavir\Product containing precisely lopinavir 133.3 milligram and ritonavir 33.3 milligram/1 each conventional release oral capsule\Kaletra capsules (Abbott Laboratories Ltd)
• \Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing protease inhibitor\Product containing ritonavir\Product containing lopinavir and ritonavir\Product containing lopinavir and ritonavir in oral dose form (medicinal product form)\Product containing only lopinavir and ritonavir in oral dose form (medicinal product form)\Product containing precisely lopinavir 133.3 milligram and ritonavir 33.3 milligram/1 each conventional release oral capsule\Kaletra capsules (Abbott Laboratories Ltd)
• \Medicinal product\Medicinal product categorized by structure\Product containing organic acid and/or organic acid derivative (product)\Product containing carboxylic acid and/or carboxylic acid derivative (product)\Product containing carbamate\Product containing ritonavir\Product containing ritonavir in oral dose form (medicinal product form)\Product containing lopinavir and ritonavir in oral dose form (medicinal product form)\Product containing only lopinavir and ritonavir in oral dose form (medicinal product form)\Product containing precisely lopinavir 133.3 milligram and ritonavir 33.3 milligram/1 each conventional release oral capsule\Kaletra capsules (Abbott Laboratories Ltd)
• \Medicinal product\Medicinal product categorized by structure\Product containing organic acid and/or organic acid derivative (product)\Product containing carboxylic acid and/or carboxylic acid derivative (product)\Product containing carbamate\Product containing ritonavir\Product containing lopinavir and ritonavir\Lopinavir + Ritonavir\Product containing only lopinavir and ritonavir in oral dose form (medicinal product form)\Product containing precisely lopinavir 133.3 milligram and ritonavir 33.3 milligram/1 each conventional release oral capsule\Kaletra capsules (Abbott Laboratories Ltd)
• \Medicinal product\Medicinal product categorized by structure\Product containing organic acid and/or organic acid derivative (product)\Product containing carboxylic acid and/or carboxylic acid derivative (product)\Product containing carbamate\Product containing ritonavir\Product containing lopinavir and ritonavir\Lopinavir + Ritonavir\Product containing precisely lopinavir 133.3 milligram and ritonavir 33.3 milligram/1 each conventional release oral capsule\Kaletra capsules (Abbott Laboratories Ltd)
• \Medicinal product\Medicinal product categorized by structure\Product containing organic acid and/or organic acid derivative (product)\Product containing carboxylic acid and/or carboxylic acid derivative (product)\Product containing carbamate\Product containing ritonavir\Product containing lopinavir and ritonavir\Product containing lopinavir and ritonavir in oral dose form (medicinal product form)\Product containing only lopinavir and ritonavir in oral dose form (medicinal product form)\Product containing precisely lopinavir 133.3 milligram and ritonavir 33.3 milligram/1 each conventional release oral capsule\Kaletra capsules (Abbott Laboratories Ltd)
• \Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing lopinavir\Product containing lopinavir in oral dose form (medicinal product form)\Product containing lopinavir and ritonavir in oral dose form (medicinal product form)\Product containing only lopinavir and ritonavir in oral dose form (medicinal product form)\Product containing precisely lopinavir 133.3 milligram and ritonavir 33.3 milligram/1 each conventional release oral capsule\Kaletra capsules (Abbott Laboratories Ltd)
• \Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing lopinavir\Product containing lopinavir and ritonavir\Lopinavir + Ritonavir\Product containing only lopinavir and ritonavir in oral dose form (medicinal product form)\Product containing precisely lopinavir 133.3 milligram and ritonavir 33.3 milligram/1 each conventional release oral capsule\Kaletra capsules (Abbott Laboratories Ltd)
• \Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing lopinavir\Product containing lopinavir and ritonavir\Lopinavir + Ritonavir\Product containing precisely lopinavir 133.3 milligram and ritonavir 33.3 milligram/1 each conventional release oral capsule\Kaletra capsules (Abbott Laboratories Ltd)
• \Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing lopinavir\Product containing lopinavir and ritonavir\Product containing lopinavir and ritonavir in oral dose form (medicinal product form)\Product containing only lopinavir and ritonavir in oral dose form (medicinal product form)\Product containing precisely lopinavir 133.3 milligram and ritonavir 33.3 milligram/1 each conventional release oral capsule\Kaletra capsules (Abbott Laboratories Ltd)
• \Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing ritonavir\Product containing ritonavir in oral dose form (medicinal product form)\Product containing lopinavir and ritonavir in oral dose form (medicinal product form)\Product containing only lopinavir and ritonavir in oral dose form (medicinal product form)\Product containing precisely lopinavir 133.3 milligram and ritonavir 33.3 milligram/1 each conventional release oral capsule\Kaletra capsules (Abbott Laboratories Ltd)
• \Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing ritonavir\Product containing lopinavir and ritonavir\Lopinavir + Ritonavir\Product containing only lopinavir and ritonavir in oral dose form (medicinal product form)\Product containing precisely lopinavir 133.3 milligram and ritonavir 33.3 milligram/1 each conventional release oral capsule\Kaletra capsules (Abbott Laboratories Ltd)
• \Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing ritonavir\Product containing lopinavir and ritonavir\Lopinavir + Ritonavir\Product containing precisely lopinavir 133.3 milligram and ritonavir 33.3 milligram/1 each conventional release oral capsule\Kaletra capsules (Abbott Laboratories Ltd)
• \Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing ritonavir\Product containing lopinavir and ritonavir\Product containing lopinavir and ritonavir in oral dose form (medicinal product form)\Product containing only lopinavir and ritonavir in oral dose form (medicinal product form)\Product containing precisely lopinavir 133.3 milligram and ritonavir 33.3 milligram/1 each conventional release oral capsule\Kaletra capsules (Abbott Laboratories Ltd)
• \Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiviral agent (product)\Medicinal product acting as antiretroviral agent (product)\Product containing lopinavir\Product containing lopinavir in oral dose form (medicinal product form)\Product containing lopinavir and ritonavir in oral dose form (medicinal product form)\Product containing only lopinavir and ritonavir in oral dose form (medicinal product form)\Product containing precisely lopinavir 133.3 milligram and ritonavir 33.3 milligram/1 each conventional release oral capsule\Kaletra capsules (Abbott Laboratories Ltd)
• \Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiviral agent (product)\Medicinal product acting as antiretroviral agent (product)\Product containing lopinavir\Product containing lopinavir and ritonavir\Lopinavir + Ritonavir\Product containing only lopinavir and ritonavir in oral dose form (medicinal product form)\Product containing precisely lopinavir 133.3 milligram and ritonavir 33.3 milligram/1 each conventional release oral capsule\Kaletra capsules (Abbott Laboratories Ltd)
• \Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiviral agent (product)\Medicinal product acting as antiretroviral agent (product)\Product containing lopinavir\Product containing lopinavir and ritonavir\Lopinavir + Ritonavir\Product containing precisely lopinavir 133.3 milligram and ritonavir 33.3 milligram/1 each conventional release oral capsule\Kaletra capsules (Abbott Laboratories Ltd)
• \Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiviral agent (product)\Medicinal product acting as antiretroviral agent (product)\Product containing lopinavir\Product containing lopinavir and ritonavir\Product containing lopinavir and ritonavir in oral dose form (medicinal product form)\Product containing only lopinavir and ritonavir in oral dose form (medicinal product form)\Product containing precisely lopinavir 133.3 milligram and ritonavir 33.3 milligram/1 each conventional release oral capsule\Kaletra capsules (Abbott Laboratories Ltd)
• \Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiviral agent (product)\Medicinal product acting as antiretroviral agent (product)\Product containing ritonavir\Product containing ritonavir in oral dose form (medicinal product form)\Product containing lopinavir and ritonavir in oral dose form (medicinal product form)\Product containing only lopinavir and ritonavir in oral dose form (medicinal product form)\Product containing precisely lopinavir 133.3 milligram and ritonavir 33.3 milligram/1 each conventional release oral capsule\Kaletra capsules (Abbott Laboratories Ltd)
• \Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiviral agent (product)\Medicinal product acting as antiretroviral agent (product)\Product containing ritonavir\Product containing lopinavir and ritonavir\Lopinavir + Ritonavir\Product containing only lopinavir and ritonavir in oral dose form (medicinal product form)\Product containing precisely lopinavir 133.3 milligram and ritonavir 33.3 milligram/1 each conventional release oral capsule\Kaletra capsules (Abbott Laboratories Ltd)
• \Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiviral agent (product)\Medicinal product acting as antiretroviral agent (product)\Product containing ritonavir\Product containing lopinavir and ritonavir\Lopinavir + Ritonavir\Product containing precisely lopinavir 133.3 milligram and ritonavir 33.3 milligram/1 each conventional release oral capsule\Kaletra capsules (Abbott Laboratories Ltd)
• \Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiviral agent (product)\Medicinal product acting as antiretroviral agent (product)\Product containing ritonavir\Product containing lopinavir and ritonavir\Product containing lopinavir and ritonavir in oral dose form (medicinal product form)\Product containing only lopinavir and ritonavir in oral dose form (medicinal product form)\Product containing precisely lopinavir 133.3 milligram and ritonavir 33.3 milligram/1 each conventional release oral capsule\Kaletra capsules (Abbott Laboratories Ltd)
• \Medicinal product\Product manufactured as oral dose form\Product containing lopinavir in oral dose form (medicinal product form)\Product containing lopinavir and ritonavir in oral dose form (medicinal product form)\Product containing only lopinavir and ritonavir in oral dose form (medicinal product form)\Product containing precisely lopinavir 133.3 milligram and ritonavir 33.3 milligram/1 each conventional release oral capsule\Kaletra capsules (Abbott Laboratories Ltd)
• \Medicinal product\Product manufactured as oral dose form\Product containing ritonavir in oral dose form (medicinal product form)\Product containing lopinavir and ritonavir in oral dose form (medicinal product form)\Product containing only lopinavir and ritonavir in oral dose form (medicinal product form)\Product containing precisely lopinavir 133.3 milligram and ritonavir 33.3 milligram/1 each conventional release oral capsule\Kaletra capsules (Abbott Laboratories Ltd)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id	Description	Lang	Type	Status	Case?	Module
18130101000001113	Kaletra capsules (Abbott Laboratories Ltd) (product)	en	Fully specified name	Active	Only initial character case insensitive	SNOMED CT United Kingdom drug extension module
38455501000001112	Kaletra 133.3mg/33.3mg capsules (Abbott Laboratories Ltd)	en	Synonym	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module

Expanded Value Set

This concept is not in any reference sets

Back to Start